Hydrocodone Bitartrate And Ibuprofen Tablet
FDA Label NDC 53746-146

29 label sections · Submitted to the FDA by Amneal Pharmaceuticals Of New York Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Of New York Llc for the product Hydrocodone Bitartrate And Ibuprofen (NDC 53746-146). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: serious and life-threatening risks from use of hydrocodone bitartrate and ibuprofen tablets, description, clinical pharmacology, clinical studies, indications and usage, contraindications, warnings, addiction, abuse, and misuse, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.